John Evans is the founder of Beam Therapeutics. Beam Therapeutics has raised $1B in total funding. Latest round: IPO. Based in Cambridge, USA.
John Evans is the CEO of Beam Therapeutics, a biotechnology company focused on base editing and genome editing technologies. He leads the company, which is headquartered in Cambridge, Massachusetts, and was founded with backing from F-Prime Capital Partners and ARCH Venture Partners.
Full founder directory · Investor directory · Company funding database · Fundraising library